ANDA 89281, held by Quad Pharmaceuticals. Dexamethasone Sodium Phosphate.
As of Nov 21, 2026, ANDA 89281 (Dexamethasone Sodium Phosphate), held by Quad Pharmaceuticals, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Dexamethasone Sodium PhosphateEQ 10MG PHOSPHATE/ML · injectable; injection | Dexamethasone Sodium Phosphate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters